Publications by authors named "Alberto Pullara"
Timing, positioning and ancillary therapies: the triad for successful Impella RP.
J Cardiovasc Med (Hagerstown)
December 2023
Clear clinical guidelines for the assessment and treatment of right ventricular failure (RVF) remain an unmet need. Although high complexity patients are common in this setting, the ideal management remains uncertain, resulting in high mortality rates despite presumably optimal medical therapy. Timely treatment with Impella RP may offer benefits by supplying circulatory support during the acute RVF phase and providing the time and unloading necessary for native right heart recovery.
View Article and Find Full Text PDFWhen axillary/subclavian arteries are not suitable because of size or anatomy, alternative access for the Impella pump 5.0/5.5 via the innominate artery allows circulatory support and eventually de-escalation from VA-ECMO to isolated left-side support.
View Article and Find Full Text PDFAim: To investigate the very long-term clinical outcomes of atrial septal defect (ASD) percutaneous closure in adult patients and to evaluate the 12-month effects of the device on aortic and mitral valve function.
Methods: Over a 12-year period, a total of 110 consecutive patients underwent percutaneous ASD closure. A yearly clinical follow-up was conducted and any adverse event was recorded.
Article Synopsis
- Postpericardiotomy syndrome, postoperative atrial fibrillation (AF), and effusions can lead to higher health care costs after cardiac surgery, but colchicine may help reduce these issues.
- This study was a double-blind, placebo-controlled trial involving 360 cardiac surgery patients across 11 Italian centers, assessing the effectiveness of colchicine taken before and after surgery.
- Results showed that there was a significant reduction in postpericardiotomy syndrome for those taking colchicine (19.4% vs. 29.4% for placebo), but no major difference in rates of postoperative AF or effusions between the two groups.
Aim: The aim of this study was to evaluate short- and long-term results of PCI (percutaneous coronary intervention) in patients with small vessel coronary artery disease and the prognostic impact of the extension and the length of coronary lesions.
Methods And Results: All consecutive patients treated with PCI in our centre between July 2002 and December 2004 were included and divided into two groups according to the diameter of the implanted stents: small vessel disease was defined as requiring implantation of stents < 2.75 mm in diameter.